Intersect ENT Inc.

Intersect ENT Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.9
Market Cap
$673.66 M
Shares Outstanding
31.25 M
Public Float
29.58 M

Profile

Address
1555 Adams Drive
Menlo Park California 94025
United States
Employees -
Website http://www.intersectent.com
Updated 07/08/2019
Intersect ENT, Inc. is acommercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Financials

View All

Lisa D. Earnhardt
President, Chief Executive Officer & Director
Cynthia L. Lucchese
Independent Director